These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29275931)

  • 1. Palliative use of furosemide in continuous subcutaneous infusion in a renal transplant patient with heart failure.
    Picazo Sánchez M; Castillo Lorenzo MN; Cuxart Pérez M; Sans Lorman R
    Nefrologia (Engl Ed); 2018; 38(4):438-439. PubMed ID: 29275931
    [No Abstract]   [Full Text] [Related]  

  • 2. Home subcutaneous infusion of furosemide in advanced decompensated heart failure.
    Sancho-Zamora MA
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):241-2. PubMed ID: 24774406
    [No Abstract]   [Full Text] [Related]  

  • 3. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response.
    Zatarain-Nicolás E; de la Fuente-Galán L; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):242. PubMed ID: 24774407
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.
    Zatarain-Nicolás E; López-Díaz J; de la Fuente-Galán L; García-Pardo H; Recio-Platero A; San Román-Calvar JA
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):1002-4. PubMed ID: 24774118
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
    Afari ME; Aoun J; Khare S; Tsao L
    Heart Fail Rev; 2019 May; 24(3):309-313. PubMed ID: 30617666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous Furosemide in Patients With Refractory Heart Failure.
    Lozano Bahamonde A; Escolar Pérez V; Echebarria Chousa A; Azcona Lucio A; Alfambra Vicente S; Rodríguez Rodríguez B
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):500-502. PubMed ID: 30029975
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety.
    Ng TM; Hshieh S; Chan CY; Elkayam U
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous furosemide in patients with refractory heart failure.
    Lozano Bahamonde A; Escolar Pérez V; Laskibar Asua A; Rodríguez Rodríguez M; Murga Eizagaechevarria N
    BMJ Support Palliat Care; 2018 Sep; 8(3):354-355. PubMed ID: 29903849
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous furosemide in advanced heart failure: has clinical practice run ahead of the evidence base?
    Beattie JM; Johnson MJ
    BMJ Support Palliat Care; 2012 Mar; 2(1):5-6. PubMed ID: 24653487
    [No Abstract]   [Full Text] [Related]  

  • 10. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
    Aaser E; Gullestad L; Tølløfsrud S; Lundberg J; Hall C; Djøseland O; Kjekshus J; Forfang K
    Scand J Clin Lab Invest; 1997 Jul; 57(4):361-7. PubMed ID: 9249883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
    Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
    J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Ng KT; Yap JLL
    Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing parenteral diuretic treatment of decompensated heart failure in the community.
    Austin J; Hockey D; Williams WR; Hutchison S
    Br J Community Nurs; 2013 Nov; 18(11):528, 530-4. PubMed ID: 24471224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of furosemide-mannitol infusion in hospitalized patients with heart failure: an observational single-center cohort study of 122 patients.
    Turagam MK; Velagapudi P; Kalra AS; Ramalingam VS; Sinnakirouchenan R; Holley JL
    Int J Cardiol; 2011 Sep; 151(2):232-4. PubMed ID: 21703703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Furosemide bolus in acute heart failure].
    Füeßl HS
    MMW Fortschr Med; 2014 Nov; 156 Spec no 2():34. PubMed ID: 25552013
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which dosing of furosemide is better in acute decompensated heart failure?
    Jalaba S; Palermo J; Budavari AI
    JAAPA; 2017 Mar; 30(3):11-12. PubMed ID: 28221314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.